Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants

Am J Physiol Gastrointest Liver Physiol. 2008 Aug;295(2):G260-72. doi: 10.1152/ajpgi.00056.2008. Epub 2008 Jun 12.

Abstract

Mechanisms by which gut luminal content regulates secretion and motility are ill understood. We evaluated whether neuroendocrine enterochromaffin (EC) cells act as luminal sensors for a wide variety of nutrients and defined the secretory mechanisms of this process. Pure (98-99%) FACS-sorted human EC cells and neoplastic EC cells (KRJ-I) were studied. RT-PCR identified transcripts for T2R1 (bitter), OR1G1 (class II olfactory) and trace amine (TAR1) G protein-coupled receptors (GPCRs) and transporters for glutamine (SNAT1/2), glucose (GLUT1/3/SGLT1), and bile salts (ABST). Glutamine and sodium deoxycholate stimulated 5-HT release (EC(50) = 0.002-0.2 microM; 2-fold release) but were 10-100 times more potent in neoplastic EC cells, which also secreted 6-13 times more 5-HT. Tastants (caffeine, tyramine, octopamine) and olfactants (thymol and eugenol) also stimulated normal and neoplastic EC cell 5-HT secretion (EC(50) = 1.2 nM to 2.1 microM and 0.05 nM to 0.1 microM release, respectively); 2-deoxyglucose and the artificial sweetener sucralose also stimulated (EC(50) = 9.2 and 0.38 nM). 5-HT release was associated with ERK phosphorylation (1.5-fold, P < 0.02) and could be inhibited by a somatostatin analog (IC(50) = 1 pM). Eleven secretory associated genes including the vesicle docking inhibitor STXBP3 were upregulated in response to glutamine and bile salt stimulation in neoplastic EC cells. Targeting STXBP3 expression by use of antisense knockdown significantly (P < 0.05) reduced 5-HT secretion. In conclusion, EC cells express GPCRs and transporters for luminal tastants, olfactants, glutamine, glucose, and bile salts. Activation includes a panel of secretory genes, ERK phosphorylation, and 5-HT secretion. Luminal EC cell regulation is likely to be as important as G cell regulation in gastric acid secretion; development of agents to target EC cell function is therefore a critical therapeutic goal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Transport System A / physiology
  • Bile Acids and Salts / physiology*
  • Caffeine / pharmacology
  • Carcinoid Tumor / genetics
  • Carcinoid Tumor / metabolism*
  • Cell Line, Tumor
  • Deoxycholic Acid / pharmacology
  • Deoxyglucose / pharmacology
  • Enterochromaffin Cells / drug effects
  • Enterochromaffin Cells / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / physiology
  • Glucose Transport Proteins, Facilitative / physiology
  • Glutamine / pharmacology
  • Humans
  • Intestinal Neoplasms / genetics
  • Intestinal Neoplasms / metabolism*
  • Intestine, Small
  • Organic Anion Transporters, Sodium-Dependent / physiology
  • Receptors, G-Protein-Coupled / physiology
  • Receptors, Metabotropic Glutamate / physiology
  • Receptors, Odorant / physiology
  • Serotonin / metabolism*
  • Sodium-Glucose Transporter 1 / physiology
  • Somatostatin / pharmacology
  • Sucrose / analogs & derivatives
  • Sucrose / pharmacology
  • Symporters / physiology
  • Tyrosine / pharmacology

Substances

  • Amino Acid Transport System A
  • Bile Acids and Salts
  • Glucose Transport Proteins, Facilitative
  • Organic Anion Transporters, Sodium-Dependent
  • Receptors, G-Protein-Coupled
  • Receptors, Metabotropic Glutamate
  • Receptors, Odorant
  • SLC38A2 protein, human
  • SLC5A1 protein, human
  • Sodium-Glucose Transporter 1
  • Symporters
  • taste receptors, type 1
  • taste receptors, type 2
  • Deoxycholic Acid
  • Glutamine
  • sodium-bile acid cotransporter
  • Serotonin
  • Caffeine
  • Tyrosine
  • Somatostatin
  • Sucrose
  • trichlorosucrose
  • Deoxyglucose
  • Extracellular Signal-Regulated MAP Kinases
  • Trace amine-associated receptor 1
  • metabotropic glutamate receptor 4